Your browser doesn't support javascript.
loading
SF1-Specific AMPKα1 Deletion Protects Against Diet-Induced Obesity.
Seoane-Collazo, Patricia; Roa, Juan; Rial-Pensado, Eva; Liñares-Pose, Laura; Beiroa, Daniel; Ruíz-Pino, Francisco; López-González, Tania; Morgan, Donald A; Pardavila, José Ángel; Sánchez-Tapia, María Jesús; Martínez-Sánchez, Noelia; Contreras, Cristina; Fidalgo, Miguel; Diéguez, Carlos; Coppari, Roberto; Rahmouni, Kamal; Nogueiras, Rubén; Tena-Sempere, Manuel; López, Miguel.
Affiliation
  • Seoane-Collazo P; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Roa J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Rial-Pensado E; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Liñares-Pose L; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Instituto Maimónides de Investigación Biomédica (IMIBIC)/Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Beiroa D; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Ruíz-Pino F; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • López-González T; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Morgan DA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Pardavila JÁ; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Sánchez-Tapia MJ; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Martínez-Sánchez N; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Contreras C; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Instituto Maimónides de Investigación Biomédica (IMIBIC)/Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Fidalgo M; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Diéguez C; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Coppari R; Department of Pharmacology, University of Iowa, Iowa City, IA.
  • Rahmouni K; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Nogueiras R; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Tena-Sempere M; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Instituto Maimónides de Investigación Biomédica (IMIBIC)/Hospital Universitario Reina Sofía, Córdoba, Spain.
  • López M; Department of Physiology, CiMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
Diabetes ; 67(11): 2213-2226, 2018 11.
Article in En | MEDLINE | ID: mdl-30104247
ABSTRACT
AMPK is a cellular gauge that is activated under conditions of low energy, increasing energy production and reducing energy waste. Current evidence links hypothalamic AMPK with the central regulation of energy balance. However, it is unclear whether targeting hypothalamic AMPK has beneficial effects in obesity. Here, we show that genetic inhibition of AMPK in the ventromedial nucleus of the hypothalamus (VMH) protects against high-fat diet (HFD)-induced obesity by increasing brown adipose tissue (BAT) thermogenesis and subsequently energy expenditure. Notably, this effect depends upon the AMPKα1 isoform in steroidogenic factor 1 (SF1) neurons of the VMH, since mice bearing selective ablation of AMPKα1 in SF1 neurons display resistance to diet-induced obesity, increased BAT thermogenesis, browning of white adipose tissue, and improved glucose and lipid homeostasis. Overall, our findings point to hypothalamic AMPK in specific neuronal populations as a potential druggable target for the treatment of obesity and associated metabolic disorders.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ventromedial Hypothalamic Nucleus / AMP-Activated Protein Kinases / Diet, High-Fat / RNA Splicing Factors / Neurons / Obesity Type of study: Etiology_studies Limits: Animals Language: En Journal: Diabetes Year: 2018 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ventromedial Hypothalamic Nucleus / AMP-Activated Protein Kinases / Diet, High-Fat / RNA Splicing Factors / Neurons / Obesity Type of study: Etiology_studies Limits: Animals Language: En Journal: Diabetes Year: 2018 Document type: Article Affiliation country: España